Related references
Note: Only part of the references are listed.Effect of renal denervation in attenuating the stress of morning surge in blood pressure: post-hoc analysis from the SPYRAL HTN-ON MED trial
Kazuomi Kario et al.
CLINICAL RESEARCH IN CARDIOLOGY (2021)
Renal sympathetic denervation lowers systemic vascular resistance in true treatment-resistant hypertension
Kaja K. Bergo et al.
BLOOD PRESSURE (2021)
Copeptin Levels in Patients With Treatment-Resistant Hypertension Before and 6 Months After Renal Denervation
Agnes Bosch et al.
AMERICAN JOURNAL OF HYPERTENSION (2020)
Rationale and design of two randomized sham-controlled trials of catheter-based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN-OFF MED Pivotal) and presence (SPYRAL HTN-ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design
Michael Boehm et al.
CLINICAL RESEARCH IN CARDIOLOGY (2020)
Changes in Stroke Volume After Renal Denervation Insight From Cardiac Magnetic Resonance Imaging
Philip Lurz et al.
HYPERTENSION (2020)
The REDUCE HTN: REINFORCE Randomized, Sham-Controlled Trial of Bipolar Radiofrequency Renal Denervation for the Treatment of Hypertension
Michael A. Weber et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2020)
Alcohol-Mediated Renal Denervation Using the Peregrine System Infusion Catheter for Treatment of Hypertension
Felix Mahfoud et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2020)
Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis
Filippo Scalise et al.
JOURNAL OF HYPERTENSION (2020)
Rationale and design of two randomized sham-controlled of catheter-based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN-OFF MED Pivotal) and presence (SPYRAL HTN-ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design (vol 109, pg 289, 2020)
Michael Boehm et al.
CLINICAL RESEARCH IN CARDIOLOGY (2020)
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial
Michael Bohm et al.
LANCET (2020)
Renal Denervation in High-Risk Patients With Hypertension
Felix Mahfoud et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
TCT CONNECT-416 Powerful Antihypertensive Effect of Anatomically Optimized Distal Renal Denervation 3 Years After the Procedure According to a Double-Blind Randomized Controlled Study
Stanislav Pekarskiy
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
TCT CONNECT-417 Impact of Renal Denervation on Plasma Renin Activity and Relationship of Baseline Plasma Renin Activity to Blood Pressure Lowering Response to Renal Denervation in the SPYRAL HTN-OFF MED Pivotal trial
Felix Mahfoud et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
A Pilot Study of Perioperative External Circumferential Cryoablation of Human Renal Arteries for Sympathetic Denervation
Claes Forssell et al.
VASCULAR SPECIALIST INTERNATIONAL (2020)
Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control After Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial
Michel Azizi et al.
CIRCULATION (2019)
Sufficient and Persistent Blood Pressure Reduction in the Final Long-Term Results From SYMPLICITY HTN-Japan - Safety and Efficacy of Renal Denervation at 3 Years -
Kazuomi Kario et al.
CIRCULATION JOURNAL (2019)
TREATMENT-BLINDED MEDICATION TITRATION FOR HYPERTENSION CONTROL FOLLOWING RANDOMIZATION TO ENDOVASCULAR ULTRASOUND RENAL DENERVATION OR A SHAM PROCEDURE
Michel Azizi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Safety and Efficacy of a New Renal Denervation Catheter in Hypertensive Patients in the Absent of Antihypertensive Medications: A Pilot Study
Yang Li et al.
INTERNATIONAL JOURNAL OF HYPERTENSION (2019)
Renal Denervation for Resistant Hypertension in the contemporary era: A Systematic Review and Meta-analysis
Pradyumna Agasthi et al.
SCIENTIFIC REPORTS (2019)
Distal renal denervation: possibilities of cardioprotection in patients with resistant arterial hypertension
E. S. Sitkova et al.
CARDIOVASCULAR THERAPY AND PREVENTION (2019)
Abstract 109: Changes in Plasma Renin Activity After Renal Denervation in the Spyral Htn-Off Med Trial
Felix Mahfoud et al.
HYPERTENSION (2019)
P4564Sympathetic renal denervation in patients with refractory arterial hypertension: 2-years follow-up
Z Shugushev et al.
EUROPEAN HEART JOURNAL (2019)
1201Cardiac function, structure, and speckle-tracking echocardiography-derived parameters after distal and conventional renal denervation: a double-blind randomized study
T Ripp et al.
EUROPEAN HEART JOURNAL (2019)
Clinic Versus Ambulatory Blood Pressure in Resistant Hypertension: Impact of Antihypertensive Medication Nonadherence: A Post Hoc Analysis the DENERHTN Study
Idir Hamdidouche et al.
HYPERTENSION (2019)
Sympathetic Renal Denervation in Patients With Refractory Arterial Hypertension: 2-Year Follow-Up
Zaur Shugushev et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
ReferencesEfficiency and safety of renal denervation via cryoablation (Cryo-RDN) in Chinese patients with uncontrolled hypertension: study protocol for a randomized controlled trial
Han Chen et al.
TRIALS (2019)
Ambulatory heart rate reduction after catheter-based renal denervation in hypertensive patients not receiving anti-hypertensive medications: data from SPYRAL HTN-OFF MED, a randomized, sham-controlled, proof-of-concept trial
Michael Boehm et al.
EUROPEAN HEART JOURNAL (2019)
Efficiency and safety of renal denervation via cryoablation (Cryo-RDN) in Chinese patients with uncontrolled hypertension: study protocol for a randomized controlled trial (vol 20, 653, 2019)
Han Chen et al.
TRIALS (2019)
Comparison of standard renal denervation procedure versus novel distal and branch vessel procedure with brachial arterial access
Ivo Petrov et al.
CARDIOVASCULAR REVASCULARIZATION MEDICINE (2019)
Renal sympathetic denervation restores aortic distensibility in patients with resistant hypertension: data from a multi-center trial
Lukas Stoiber et al.
CLINICAL RESEARCH IN CARDIOLOGY (2018)
Renal Denervation in Resistant Hypertension and Obstructive Sleep Apnea: Randomized Proof-of-Concept Phase II Trial
Ewa Warchol-Celinska et al.
HYPERTENSION (2018)
Effects of renal denervation on coronary flow reserve and forearm dilation capacity in patients with treatment-resistant hypertension. A randomized, double-blinded, sham-controlled clinical trial
Morten Engholm et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Organ damage changes in patients with resistant hypertension randomized to renal denervation or spironolactone: The DENERVHTA (Denervacion en Hipertension Arterial) study
Anna Oliveras et al.
JOURNAL OF CLINICAL HYPERTENSION (2018)
CHEMICAL RENAL DENERVATION WITH ALCOHOL - LONG TERM RESULTS FROM THE PEREGRINE POST-MARKET STUDY
A. Persu et al.
JOURNAL OF HYPERTENSION (2018)
RADIANCE-HTN SOLO: A MULTICENTER, RANDOMIZED, SHAM-CONTROLLED STUDY OF RENAL DENERVATION IN PATIENTS WITH UNCONTROLLED HYPERTENSION IN THE ABSENCE OF ANTIHYPERTENSIVE MEDICATIONS
M. Azizi et al.
JOURNAL OF HYPERTENSION (2018)
LONG-TERM OUTCOME OF THE RANDOMIZED OSLO-RDN STUDY
C. Lund Soeraas et al.
JOURNAL OF HYPERTENSION (2018)
SPYRAL HTN-OFF MED TRIAL: CHANGES IN OFFICE AND AMBULATORY HEART RATE
M. Bohm et al.
JOURNAL OF HYPERTENSION (2018)
Phase II randomized sham-controlled study of renal denervation for individuals with uncontrolled hypertension - WAVE IV
Roland E. Schmieder et al.
JOURNAL OF HYPERTENSION (2018)
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial
David E. Kandzari et al.
LANCET (2018)
Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial
Michel Azizi et al.
LANCET (2018)
Twenty-Four-Hour Ambulatory Blood Pressure Reduction Patterns After Renal Denervation in the SPYRAL HTN-OFF MED Trial
Kazuomi Kario et al.
CIRCULATION (2018)
Medication adherence in patients with apparent resistant hypertension: findings from the SYMPATHY trial
Rosa L. de Jager et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Renal Denervation vs. Spironolactone in Resistant Hypertension: Effects on Circadian Patterns and Blood Pressure Variability
Alejandro de la Sierra et al.
AMERICAN JOURNAL OF HYPERTENSION (2017)
Impact of Medication Adherence on the Effect of Renal Denervation: The SYMPATHY Trial
Rosa L. de Jager et al.
HYPERTENSION (2017)
Salt intake and blood pressure response to percutaneous renal denervation in resistant hypertension
Esther de Beus et al.
JOURNAL OF CLINICAL HYPERTENSION (2017)
Feasibility of catheter ablation renal denervation in mild resistant hypertension
Shaojie Chen et al.
JOURNAL OF CLINICAL HYPERTENSION (2017)
EFFECTS OF MULTIELECTRODE RENAL DENERVATION ON SYMPATHETIC NERVE ACTIVITY AND INSULIN RESISTANCE IN METABOLIC SYNDROME
K. Dimitriadis et al.
JOURNAL OF HYPERTENSION (2017)
PHASE II RANDOMIZED SHAM-CONTROLLED STUDY OF RENAL DENERVATION FOR SUBJECTS WITH UNCONTROLLED HYPERTENSION - WAVE IV
R. E. Schmieder et al.
JOURNAL OF HYPERTENSION (2017)
Renal denervation in comparison with intensified pharmacotherapy in true resistant hypertension: 2-year outcomes of randomized PRAGUE-15 study
Jan Rosa et al.
JOURNAL OF HYPERTENSION (2017)
Ultrasound-based renal sympathetic denervation for the treatment of therapy-resistant hypertension: a single-center experience
Karl Fengler et al.
JOURNAL OF HYPERTENSION (2017)
A distal mode of renal denervation in segmental branches of renal artery versus conventional main trunk therapy: a double blind randomized controlled study in patients with resistant hypertension
Andrei Baev et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial
Raymond R. Townsend et al.
LANCET (2017)
MO015MEDICATION ADHERENCE IN PATIENTS WITH APPARENT RESISTANT HYPERTENSION: FINDINGS FROM THE SYMPATHY TRIAL
Rosa de Jager et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Efficacy and safety of renal denervation for Chinese patients with resistant hypertension using a microirrigated catheter: study design and protocol for a prospective multicentre randomised controlled trial
Zongjun Liu et al.
BMJ OPEN (2017)
Abdominal Aortic Calcifications Influences the Systemic and Renal Hemodynamic Response to Renal Denervation in the DENERHTN (Renal Denervation for Hypertension) Trial
Pierre-Yves Courand et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
The Effect of Renal Denervation on Plasma Adipokine Profile in Patients With Treatment Resistant Hypertension
Nina Eikelis et al.
FRONTIERS IN PHYSIOLOGY (2017)
Sham or no sham control: that is the question in trials of renal denervation for resistant hypertension. A systematic meta-analysis
Fadl Elmula M. Fadl Elmula et al.
BLOOD PRESSURE (2017)
The effect of renal denervation on arterial stiffness, central blood pressure and heart rate variability in treatment resistant essential hypertension: a substudy of a randomized sham-controlled double-blinded trial (the ReSET trial)
Christian Daugaard Peters et al.
BLOOD PRESSURE (2017)
Results of a randomized controlled pilot trial of intravascular renal denervation for management of treatment-resistant hypertension
Lotte Jacobs et al.
BLOOD PRESSURE (2017)
Role of Adding Spironolactone and Renal Denervation in True Resistant Hypertension One-Year Outcomes of Randomized PRAGUE-15 Study
Jan Rosa et al.
HYPERTENSION (2016)
Could careful patient selection for renal denervation warrant a positive effect on arterial stiffness and left ventricular mass reduction?
Darius Palionis et al.
ACTA CARDIOLOGICA (2016)
The SPYRAL HTN Global Clinical Trial Program: Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications
David E. Kandzari et al.
AMERICAN HEART JOURNAL (2016)
Renal denervation improves exercise blood pressure: insights from a randomized, sham-controlled trial
Karl Fengler et al.
CLINICAL RESEARCH IN CARDIOLOGY (2016)
EFFECTS OF MULTIELECTRODE RENAL DENERVATION ON SYMPATHETIC NERVE ACTIVITY AND INSULIN RESISTANCE IN METABOLIC SYNDROME
C. Tsioufis et al.
JOURNAL OF HYPERTENSION (2016)
PRESENCE OF AORTIC ABDOMINAL CALCIFICATIONS IN PATIENTS WITH RESISTANT HYPERTENSION AND BP RESPONSE IN THE RENAL DENERVATION FOR HYPERTENSION (DENERHTN) TRIAL
P-Y Courand et al.
JOURNAL OF HYPERTENSION (2016)
RENAL DENERVATION IN HYPERTENSIVE PATIENTS NOT ON BLOOD PRESSURE LOWERING DRUGS
M. Sanders et al.
JOURNAL OF HYPERTENSION (2016)
CHANGES IN SUBCLINICAL ORGAN DAMAGE IN PATIENTS WITH RESISTANT HYPERTENSION RANDOMIZED TO RECEIVE RENAL DENERVATION OR SPIRONOLACTONE AS ADD-ON THERAPY. THE DENERVHTA STUDY RESULTS
A. Oliveras et al.
JOURNAL OF HYPERTENSION (2016)
RENAL DENERVATION VERSUS SPIRONOLACTONE IN RESISTANT HYPERTENSION. EFFECTS ON CIRCADIAN PATTERNS AND BLOOD PRESSURE VARIABILITY
A. De La Sierra et al.
JOURNAL OF HYPERTENSION (2016)
Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial
Ole N. Mathiassen et al.
JOURNAL OF HYPERTENSION (2016)
The “RADIANCE-HTN” clinical study: a two-cohort study design to evaluate the effectiveness of the paradise renal denervation system in patients with hypertension
Michel Azizi et al.
Journal of the American Society of Hypertension (2016)
SYMPLICITY HTN-Japan - First Randomized Controlled Trial of Catheter-Based Renal Denervation in Asian Patients -
Kazuomi Kario et al.
CIRCULATION JOURNAL (2015)
Blood Pressure Responses to Renal Denervation Precede and Are Independent of the Sympathetic and Baroreflex Effects
Guido Grassi et al.
HYPERTENSION (2015)
Randomized Sham-Controlled Trial of Renal Sympathetic Denervation in Mild Resistant Hypertension
Steffen Desch et al.
HYPERTENSION (2015)
PREFERENTIAL REDUCTION IN MORNING/NOCTURNAL HYPERTENSION BY RENAL DENERVATION FOR DRUG-RESISTANT HYPERTENSION: A NEW ABPM ANALYSIS OF SYMPLICITY HTN-3 AND HTN-JAPAN
K. Kario et al.
JOURNAL OF HYPERTENSION (2015)
PREVALENCE AND RISK FACTORS FOR REFRACTORY HYPERTENSION IN THE DENERHTN STUDY
V. Forni Ogna et al.
JOURNAL OF HYPERTENSION (2015)
FAILURE OF RENAL DENERVATION IN SYMPLICITY HTN-3 IS A PREDICTABLE RESULT OF ANATOMICALLY INADEQUATE OPERATIVE TECHNIQUE AND NOT THE TRUE LIMITATIONS OF THE TECHNOLOGY
S. Pekarskiy et al.
JOURNAL OF HYPERTENSION (2015)
Long-term (24-month) blood pressure results of catheter-based renal artery denervation: SYMPLICITY HTN-3 Randomized Controlled Trial
Deepak L. Bhatt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Renal Sympathetic Denervation in Treatment Resistant Essential Hypertension. A Sham-Controlled, Double-blinded Randomized Trial (ReSET trial)
Ole N. Mathiassen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trial
John M. Flack et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2015)
Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial
Michel Azizi et al.
LANCET (2015)
Renal denervation: Not as easy as it looks
Murray Esler
SCIENCE TRANSLATIONAL MEDICINE (2015)
Predictors of blood pressure response in the SYMPLICITY HTN-3 trial
David E. Kandzari et al.
EUROPEAN HEART JOURNAL (2015)
12-Month Blood Pressure Results of Catheter-Based Renal Artery Denervation for Resistant Hypertension The SYMPLICITY HTN-3 Trial
George L. Bakris et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Randomized Comparison of Renal Denervation Versus Intensified Pharmacotherapy Including Spironolactone in True-Resistant Hypertension Six-Month Results From the Prague-15 Study
Jan Rosa et al.
HYPERTENSION (2015)
The effect of renal denervation added to standard pharmacologic treatment versus standard pharmacologic treatment alone in patients with resistant hypertension: Rationale and design of the SYMPATHY trial
Eva E. Vink et al.
AMERICAN HEART JOURNAL (2014)
Renal Sympathetic Denervation for the Treatment of Refractory Hypertension
Kui Toh Gerard Leong et al.
ANNUAL REVIEW OF MEDICINE, VOL 65 (2014)
Renal denervation in treatment-resistant hypertension - Oslo RDN, Symplicity HTN-3 and INSPiRED randomized trials
Sverre E. Kjeldsen et al.
BLOOD PRESSURE (2014)
Rationale and design of the Investigator-Steered Project on intravascular Renal Denervation for Management of Drug-Resistant Hypertension (INSPiRED) trial
Yu Jin et al.
BLOOD PRESSURE (2014)
Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial
Felix Mahfoud et al.
EUROPEAN HEART JOURNAL (2014)
Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial
Murray D. Esler et al.
EUROPEAN HEART JOURNAL (2014)
Renal denervation for improving outcomes of catheter ablation in patients with atrial fibrillation and hypertension: Early experience
Evgeny Pokushalov et al.
HEART RHYTHM (2014)
Adjusted Drug Treatment Is Superior to Renal Sympathetic Denervation in Patients With True Treatment-Resistant Hypertension
Fadl Elmula M. Fadl Elmula et al.
HYPERTENSION (2014)
The Effects of Catheter-Based Radiofrequency Renal Denervation on Renal Function and Renal Artery Structure in Patients With Resistant Hypertension
Zhi-Hui Zhang et al.
JOURNAL OF CLINICAL HYPERTENSION (2014)
Importance of thorough investigation of resistant hypertension before renal denervation: should compliance to treatment be evaluated systematically?
J. Rosa et al.
JOURNAL OF HUMAN HYPERTENSION (2014)
Apparent and true resistant hypertension: definition, prevalence and outcomes
E. Judd et al.
JOURNAL OF HUMAN HYPERTENSION (2014)
SYMPLICITY HTN-3: Outcomes in the African-American and non-African American Populations
John Flack et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
First Clinical Experience with Neurotropic Agents for Treatment of Sympathetic Hypertension
Horst Sievert et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Impact of Renal Denervation on 24-Hour Ambulatory Blood Pressure Results From SYMPLICITY HTN-3
George L. Bakris et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Anatomic Assessment of Sympathetic Peri-Arterial Renal Nerves in Man
Kenichi Sakakura et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
THE ROLE OF RENAL DENERVATION IN IMPROVING OUTCOMES OF CATHETER ABLATION IN PATIENTS WITH ATRIAL FIBRILLATION AND MODERATE RESISTANT OR RESISTANT HYPERTENSION
Evgeny Pokushalov et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
ADJUSTED DRUG TREATMENT IS SUPERIOR TO RENAL SYMPATHETIC DENERVATION IN PATIENTS WITH TRUE TREATMENT RESISTANT HYPERTENSION, A RANDOMIZED CLINICAL TRIAL
Fadl Elmula Mohamed Fadl Elmula et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Rationale and design of the investigator-steered project on intravascular renal denervation for management of drug-resistant hypertension (INSPiRED) trial
Yu Jin et al.
Journal of the American Society of Hypertension (2014)
A Controlled Trial of Renal Denervation for Resistant Hypertension
D.L. Bhatt et al.
JOURNAL OF VASCULAR SURGERY (2014)
Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study
Henry Krum et al.
LANCET (2014)
A Controlled Trial of Renal Denervation for Resistant Hypertension
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A controlled trial of renal denervation for resistant hypertension
K. E. Shipman
ANNALS OF CLINICAL BIOCHEMISTRY (2014)
Catheter-based renal denervation versus intensified medical treatment in patients with resistant hypertension: Rationale and design of a multicenter randomized study-PRAGUE-15
Petr Tousek et al.
COR ET VASA (2014)
Ambulatory Blood Pressure Changes After Renal Sympathetic Denervation in Patients With Resistant Hypertension
Felix Mahfoud et al.
CIRCULATION (2013)
Renal Denervation: A Potential New Treatment for Severe Hypertension
Yonghong Huan et al.
CLINICAL CARDIOLOGY (2013)
Renal Sympathetic Denervation in Patients With Treatment-Resistant Hypertension After Witnessed Intake of Medication Before Qualifying Ambulatory Blood Pressure
Fadl Elmula Mohamed Fadl Elmula et al.
HYPERTENSION (2013)
Adjunctive Renal Sympathetic Denervation to Modify Hypertension as Upstream Therapy in the Treatment of Atrial Fibrillation (H-FIB) Study: Clinical Background and Study Design
Humera Ahmed et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2013)
Renal nerve ablation reduces augmentation index in patients with resistant hypertension
Dagmara Hering et al.
JOURNAL OF HYPERTENSION (2013)
RENAL SYMPATHETIC DENERVATION FOR TREATMENT OF RESISTANT HYPERTENSION: TWO-YEAR UPDATE FROM THE SYMPLICITY HTN-2 RANDOMIZED CONTROLLED TRIAL
Murray Esler et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Persistent and Safe Blood Pressure Lowering Effects of Renal Artery Denervation: Three Year Follow-up From the Symplicity HTN-2 Trial
Murray D. Esler et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Effectiveness of Renal Denervation Therapy for Resistant Hypertension A Systematic Review and Meta-Analysis
Mark I. Davis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Renal sympathetic denervation versus antiarrhythmic drugs for drug-resistant hypertension and symptomatic atrial fibrillation (RSDforAF) trial: study protocol for a randomized controlled trial
Min Qiu et al.
TRIALS (2013)
Long-Term Renal Denervation Normalizes Disrupted Blood Pressure Circadian Rhythm and Ameliorates Cardiovascular Injury in a Rat Model of Metabolic Syndrome
Tetsuji Katayama et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Renal Denervation Prevents Stroke and Brain Injury via Attenuation of Oxidative Stress in Hypertensive Rats
Takashi Nakagawa et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Renal Sympathetic Denervation for Treatment of Drug-Resistant Hypertension One-Year Results From the Symplicity HTN-2 Randomized, Controlled Trial
Murray D. Esler et al.
CIRCULATION (2012)
Catheter-Based Renal Denervation for Resistant Hypertension: Rationale and Design of the SYMPLICITY HTN-3 Trial
David E. Kandzari et al.
CLINICAL CARDIOLOGY (2012)
Renal Hemodynamics and Renal Function After Catheter-Based Renal Sympathetic Denervation in Patients With Resistant Hypertension
Felix Mahfoud et al.
HYPERTENSION (2012)
Renal Sympathetic Denervation Using an Irrigated Radiofrequency Ablation Catheter for the Management of Drug-Resistant Hypertension
Humera Ahmed et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2012)
RENAL SYMPATHETIC DENERVATION FOR TREATMENT OF RESISTANT HYPERTENSION: ONE YEAR RESULTS FROM THE SYMPLICITY HTN-2 RANDOMIZED CONTROLLED TRIAL
Murray D. Esler et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Renal Sympathetic Denervation Reduces Left Ventricular Hypertrophy and Improves Cardiac Function in Patients With Resistant Hypertension
Mathias C. Brandt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Effects of Renal Sympathetic Denervation on Arterial Stiffness and Central Hemodynamics in Patients With Resistant Hypertension
Mathias C. Brandt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
A Randomized Comparison of Pulmonary Vein Isolation With Versus Without Concomitant Renal Artery Denervation in Patients With Refractory Symptomatic Atrial Fibrillation and Resistant Hypertension
Evgeny Pokushalov et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Resistant hypertension
Aung Myat et al.
BRITISH MEDICAL JOURNAL (2012)
Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant Hypertension A Pilot Study
Felix Mahfoud et al.
CIRCULATION (2011)
Effects of Renal Sympathetic Denervation on Blood Pressure, Sleep Apnea Course, and Glycemic Control in Patients With Resistant Hypertension and Sleep Apnea
Adam Witkowski et al.
HYPERTENSION (2011)
Catheter-Based Renal Sympathetic Denervation for Resistant Hypertension Durability of Blood Pressure Reduction Out to 24 Months
Jerzy Sadowski et al.
HYPERTENSION (2011)
lCardiorespiratory Response to Exercise After Renal Sympathetic Denervation in Patients With Resistant Hypertension
Christian Ukena et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
Murray D. Esler et al.
LANCET (2010)
Resistant hypertension: Diagnosis, evaluation, and treatment - A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research (Reprinted from Hypertension, vol 51, pg 1403-1419, 2008)
David A. Calhoun et al.
CIRCULATION (2008)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)